Point-of-care (POC) diagnostics reduces costs and improves patient experience as it is performed at the point of care, such as the doctor's office, care facility - and with veterinary diagnostics, at animal clinics and stables. The ability to perform rapid testing outside laboratories facilitates the diagnostic process and the early steps of beginning treatment. POC testing is also highly beneficial for monitoring treatment.
The POC procedure is easy, as you can see on this video of performing the Labmaster LUCIA™ MxA test.
Point-of-care provides an efficient and reliable method for detection, monitoring and treatment. For instance, for patients suffering from chronic diseases, POC technology is an opportunity for personalized treatment. There is a clear trend of POC testing working in a complementary role in clinical healthcare, making diagnosis faster and more accessible.
Tony Wahlroos, CEO
Labmaster’s quality management system is ISO 13485:2016 and 9001:2015 certified for the design and manufacture of in vitro diagnostic devices for detection of viral infections, immune response and inflammatory status as an aid in diagnosis. Accordingly, we can focus on delivering safe and effective products to worldwide market and add direct value for investors with technologically advanced methodology. Kirsi-Marja Meri, Regulatory Director
Labmaster LUCIA™ platform delivers quick results for healthcare professionals working in near-patient environment.
Labmaster’s CRP and MxA tests are based on a wholeblood fingertip sample. The measurement returns a quantitative result within minutes.
The recently conducted clinical study on Labmaster LUCIA MxA test shows that the elevated level of MxA (Myxovirus resistance protein A) in blood indicates viral origin of infection in patients with fever and common respiratory symptoms.
Applied together, MxA and CRP tests are effiecient tools for the differentiation between bacterial and viral respiratory tract infections. They support diagnostic decisions on whether antibiotics are required and therefore aid in tackling antimicrobial resistance (AMR).
The Labmaster LUCIA™ Vet Analyzer is a point-of-care device which makes testing easy and accessible. The measurement can be performed at point of care, such as clinics, veterinary hospitals, stables and animal care facilities.
Our veterinary pipeline for 2024 includes Thyroxine (T4), Camel SAA & Fibrinogen, Progesterone, Testosterone and Cortisol.
Efficient products based on Finnish technology
Labmaster's diagnostic products are based on proprietary technology which is accurate, fast and cost-effective. We are constantly developing new tests for our Labmaster LUCIA™ platform. All of our test are performed with the Labmaster LUCIA™ table-top analyzer which is a CE-marked device.
Ready to find out more?
We are happy to share more information with you and discuss collaboration.
Head of Global Sales
+358 400 527 905
Or leave us your contact information below, we will be in touch with you promptly.